Related Experiment Videos

Enzyme polymorphism and clinical variability of diseases: a study of diabetes mellitus

Human Biology
|August 1, 1989
PubMed

Insights

Diabetic pregnancy can lead to neonatal issues like macrosomia and hypoglycemia. Enzyme polymorphisms may influence these outcomes, suggesting low enzymatic activity negatively impacts fetal development and neonatal adaptation.

Area of Science:

  • Biochemistry
  • Genetics
  • Neonatology

Background:

  • Diabetic pregnancy is associated with specific neonatal complications.
  • Enzyme polymorphisms are common genetic variations.
  • Understanding genetic influences on neonatal health is crucial.

Purpose of the Study:

  • To investigate associations between neonatal manifestations of diabetic pregnancy and enzyme polymorphisms.
  • To explore the role of enzyme activity in fetal development and neonatal adaptation.

Main Methods:

  • Studied infants born to diabetic mothers.
  • Examined four common neonatal manifestations: macrosomia, hypoglycemia, hypocalcemia, and jaundice.
  • Analyzed four enzyme polymorphisms: PGM1, ADA, AK1, and ACP1.

Main Results:

  • Observed patterns of association between neonatal complications and enzyme polymorphisms.
  • Findings suggest low enzymatic activity may adversely affect fetal development.
  • Some enzymes also influence fetal growth in non-diabetic pregnancies.

Conclusions:

  • Enzyme polymorphisms may contribute to the clinical variability of neonatal complications in diabetic pregnancies.
  • Genetic analysis of disease patterns can enhance understanding of disease variability.
  • Low enzymatic activity could impair neonatal adaptability to the extrauterine environment.

Related Concept Videos